Intelecta

Levocarnitine, the active ingredient in Intelecta, is a nutritional supplement presented as an oral formulation for oral use. It supports the transport of long‑chain fatty acids into mitochondria, facilitating energy metabolism, and is commonly used in individuals with carnitine deficiency or increased metabolic demand.

GNH USA supplies Intelecta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Intelecta (levocarnitine) is used to address conditions related to impaired fatty‑acid metabolism and carnitine deficiency. - Primary carnitine deficiency: restores normal carnitine levels to support mitochondrial fatty‑acid oxidation. - Secondary carnitine deficiency (e.g., in renal dialysis): helps replenish depleted carnitine stores and improve energy metabolism. - Inherited metabolic disorders (e.g., organic acidemias): assists in the detoxification of toxic metabolites by enhancing β‑oxidation.

Levocarnitine may be associated with several adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset after oral intake. - Vomiting: occasional emesis, especially with high doses. - Diarrhea: loose stools that resolve upon discontinuation. - Headache: transient headache reported by some users.

Serious or Rare Side Effects: - Hypersensitivity reactions: rash, itching, or swelling indicating an allergic response. - Seizures: rare occurrence in patients with pre‑existing neurological conditions. - Muscle weakness: uncommon but may signal underlying metabolic imbalance.

When considering levocarnitine therapy, certain precautions should be observed to ensure safe use. - Assess renal function: dosage may need adjustment in severe renal impairment. - Monitor cardiac status: patients with arrhythmias should be evaluated before use. - Evaluate for metabolic disorders: confirm diagnosis of carnitine deficiency prior to initiation. - Avoid use in patients with known hypersensitivity to levocarnitine. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Levocarnitine can interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Valproic acid: may reduce carnitine levels, increasing risk of deficiency. - Certain antibiotics (e.g., carbapenems): can interfere with carnitine absorption.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): levocarnitine may potentiate anticoagulant effect, requiring INR monitoring. - Thyroid hormones: may affect metabolism, necessitating thyroid function tests. - Diuretics: increased renal excretion may lower carnitine concentrations.